RxDoctor Payments Data

Ian Skare

Psychiatric/Mental Health · Big Lake, MNNPI 1881147106

Payments from drug & device makers

$257in general payments, 2019–2025

Across 16 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$80
  • Almatica Pharma LLC$37
  • Neurocrine Biosciences, Inc.$27
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$22
  • E.r. Squibb & Sons, L.L.C.$21
  • Alkermes, Inc.$18
  • plus $51 from 4 others

What the payments were for

  • Food & beverage$257100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$257 in reported general payments places this provider in the 80th percentile of 407 psychiatric/mental health providers in Minnesota.

See all psychiatric/mental health providers in Minnesota

Medicare billing

Part B allowed, 2024
$73,906
Medicare patients
105
Services billed
862

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate26$206,645
Abilify MaintenaAripiprazole37$112,595
Invega SustennaPaliperidone Palmitate25$82,756
Lurasidone Hcl47$21,921
VraylarCariprazine Hcl13$17,667
Risperidone ErRisperidone Microspheres15$16,019
Fluphenazine Hcl55$12,107
Quetiapine Fumarate502$11,436
Olanzapine511$11,341
Aripiprazole216$11,026
Divalproex Sodium ErDivalproex Sodium128$10,867
Bupropion XlBupropion Hcl277$6,436
Lamotrigine364$5,935
Divalproex Sodium80$5,001
Clozapine52$4,976

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$27$206,64526 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$12$112,59537 claims
Johnson & JohnsonInvega Sustenna$13$82,75625 claims
AbbVieVraylar$13$17,66713 claims
Almatica Pharma LLCSertraline Hcl$37$3,117192 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 407 psychiatric/mental health providers in Minnesota.

Other psychiatric/mental health in Big Lake

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →